skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 298  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Risk Factors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
Material Type:
Article 		Add to My Research

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma

BMC cancer, 2022-08, Vol.22 (1), p.1-872, Article 872 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09967-6 ;PMID: 35945526

Full text available

Citations Cited by
22
Identification of a pyroptosis-related prognostic signature in breast cancer
Identification of a pyroptosis-related prognostic signature in breast cancer
Material Type:
Article 		Add to My Research

Identification of a pyroptosis-related prognostic signature in breast cancer

BMC cancer, 2022-04, Vol.22 (1), p.429-429, Article 429 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09526-z ;PMID: 35443644

Full text available

Citations Cited by
23
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

BMC cancer, 2020-06, Vol.20 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06995-y ;PMID: 32487048

Full text available

Citations Cited by
24
Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
Material Type:
Article 		Add to My Research

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy

BMC cancer, 2023-11, Vol.23 (1), p.1-1150, Article 1150 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11629-0

Full text available

Citations Cited by
25
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
Material Type:
Article 		Add to My Research

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data

BMC cancer, 2023-11, Vol.23 (1), p.1-1147, Article 1147 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11628-1

Full text available

Citations Cited by
26
Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysis
Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysis

BMC cancer, 2023-11, Vol.23 (1), p.1-1123, Article 1123 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11561-3

Full text available

Citations Cited by
27
Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
Material Type:
Article 		Add to My Research

Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy

BMC cancer, 2023-11, Vol.23 (1), p.1-1116, Article 1116 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11621-8

Full text available

Citations Cited by
28
Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint
Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint
Material Type:
Article 		Add to My Research

Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint

BMC cancer, 2023-11, Vol.23 (1), p.1-1062, Article 1062 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11587-7

Full text available

Citations Cited by
29
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
Material Type:
Article 		Add to My Research

The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

BMC cancer, 2023-10, Vol.23 (1), p.1-1018, Article 1018 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11523-9

Full text available

Citations Cited by
30
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

BMC cancer, 2023-01, Vol.23 (1), p.25-25, Article 25 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10461-2 ;PMID: 36611155

Full text available

Citations Cited by
31
Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis
Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis

BMC cancer, 2023-10, Vol.23 (1), p.1-933, Article 933 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11424-x ;PMID: 37789268

Full text available

Citations Cited by
32
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis

BMC cancer, 2023-07, Vol.23 (1), p.644-644, Article 644 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11049-0 ;PMID: 37430191

Full text available

Citations Cited by
33
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma

BMC cancer, 2022-04, Vol.22 (1), p.431-431, Article 431 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09530-3 ;PMID: 35443674

Full text available

Citations Cited by
34
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Material Type:
Article 		Add to My Research

Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer

BMC cancer, 2023-06, Vol.23 (1), p.576-576, Article 576 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11083-y ;PMID: 37349711

Full text available

Citations Cited by
35
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Material Type:
Article 		Add to My Research

Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

BMC cancer, 2019-06, Vol.19 (1), p.604-604, Article 604 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5814-y ;PMID: 31216997

Full text available

Citations Cited by
36
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study
Material Type:
Article 		Add to My Research

A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study

BMC cancer, 2022-08, Vol.22 (1), p.1-914, Article 914 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09796-7 ;PMID: 35999524

Full text available

Citations Cited by
37
Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis
Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis
Material Type:
Article 		Add to My Research

Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis

BMC cancer, 2021-05, Vol.21 (1), p.513-513, Article 513 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08253-1 ;PMID: 33962555

Full text available

Citations Cited by
38
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Material Type:
Article 		Add to My Research

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

BMC cancer, 2022-03, Vol.22 (1), p.287-287, Article 287 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09413-7 ;PMID: 35300634

Full text available

Citations Cited by
39
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
Material Type:
Article 		Add to My Research

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

BMC cancer, 2024-02, Vol.24 (1), p.260-260 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-11987-3 ;PMID: 38402173

Full text available

Citations Cited by
40
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial
Material Type:
Article 		Add to My Research

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

BMC cancer, 2022-12, Vol.22 (1), p.1-16 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10355-3 ;PMID: 36471257

Full text available

Citations Cited by

Results 21 - 40 of 298  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2013  (15)
  2. 2013 To 2016  (35)
  3. 2017 To 2018  (9)
  4. 2019 To 2021  (134)
  5. After 2021  (106)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait